ADVERTISEMENT

Custom Search
ADVERTISEMENT
Helpdesk Support
Today's Health Headlines
(Reuters) - U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday.

(Reuters Health) - Learning to respond to your failures with kindness, or self-compassion, may help offset the negative effects of perfectionism at any age, according to a small study of Australian teens and adults.

(Reuters Health) - Men who drink alcohol in late adolescence are more likely to develop severe liver disease decades later than young people who don’t drink at all, a Swedish study suggests.

KAMPALA (Reuters) - Twenty-six refugees from the Democratic Republic of Congo have died in a camp in Uganda from acute diarrhea, and hundreds more cases have been registered, an official from the United Nations refugee agency UNHCR said on Thursday.

(Reuters Health) - Black people with knee osteoarthritis may have a worse quality of life than white patients in part because they’re less likely to be offered knee replacement surgery or to get the procedure when it’s recommended, a U.S. study suggests.

TOKYO/SEOUL (Reuters) - The World Trade Organization largely upheld a Japanese complaint against South Korean import bans and additional testing requirements imposed on Japanese seafood because of the 2011 Fukushima nuclear disaster.

(Reuters Health) - An approach to nursing home care that fosters interest and social interaction among patients and staff may reduce agitation and other neuropsychiatric symptoms in dementia sufferers and improve their quality of life, a recent trial suggests.

(Reuters Health) - Compared to inactive people, recreational soccer players have lower cholesterol, blood pressure and resting heart rates as well as less fat mass, a research review suggests.

AMSTERDAM (Reuters) - Dutch prosecutors on Thursday rejected a call by civil groups, hospitals and the city of Amsterdam to open a criminal case against major tobacco companies, saying the firms had adequately warned smokers of the health risks.

COPENHAGEN/LONDON (Reuters) - The world's largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market.

ADVERTISEMENT
Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
ADVERTISEMENT
loading